Ventolin and Ziagen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ventolin (albuterol) and Ziagen (abacavir sulfate). Common drug interactions include pain among males.

The phase IV clinical study analyzes what interactions people have when they take Ventolin and Ziagen. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

What is Ziagen?

Ziagen has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 7,626 Ziagen users. Check the latest studies of Ziagen.



On Jul, 07, 2026

13 people who take Ventolin and Ziagen together, and have interactions are studied.

Ventolin and Ziagen drug interactions.

What are the common drug interactions of Ventolin and Ziagen, by gender? *:

female:

n/a

male:

  1. Pain
  2. Platelet count decreased
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cardiac arrest
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Dyspnoea (difficult or laboured respiration)
  7. Haematocrit decreased
  8. Headache (pain in head)
  9. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  10. Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)

What are the common drug interactions of Ventolin and Ziagen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pain
  2. Platelet count decreased
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Dyspnoea (difficult or laboured respiration)
  5. Haematocrit decreased
  6. Headache (pain in head)
  7. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  8. Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
  9. Hyporeflexia (a condition of below normal or absent reflexes)
  10. Influenza like illness

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 3 people, 23.08%
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 15.38%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin and Ziagen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ventolin and Ziagen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ziagen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ziagen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol and abacavir sulfate (the active ingredients of Ventolin and Ziagen, respectively), and Ventolin and Ziagen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: